Threadless and Strange Planet Viral Webcomic Creator, Nathan W. Pyle, Lead a New Wave of Wearable Art – Cherokee Tribune Ledger News

CHICAGO, Jan. 28, 2020 /PRNewswire/ -- Threadless, leading ecommerce apparel company and online artist community, in partnership with Nathan W. Pyle, cartoonist and New York Times best-selling author, announces the sale of over 300,000 unique items in Strange Planet merchandise thanks to Threadless Artist Shops.

Pyle, who launched his Strange Planet webcomic series in early February 2019, experienced rapid and viral success, gaining one million Instagram followers in the first five weeks. Within the comic's first year, Pyle amassed over 6.5 million followers and quickly turned to Threadless to open his Artist Shop to capitalize on the series' success.

Threadless' Artist Shops platform enables artists around the world, like Pyle, to effortlessly promote, add, fulfill, and deliver print-on-demand merchandise. In just six months, Pyle and Threadless sold hundreds of thousands of products, featuring his hilarious spin on human behavior through the lens of blue, interstellar beings. The top-selling item is t-shirts, priced on average at $20 each.

"Working with Threadless has been fantastic. I can focus on making my comics while Threadless makes high-quality merchandise available in my Artist Shop nearly instantaneously," said Nathan W. Pyle,cartoonist and New York Times best-selling author. "Being able to upload a design once and apply it to dozens of different Threadless products is super fun and easy. And they're always working on new product additions, which is super exciting to me!"

Threadless works with both amateur and seasoned artists to maintain their Artist Shops, add and promote new products and designs, support marketing efforts, and provide customer service to help artists both established and up-and-coming do exactly what Pyle has achieved.

"Threadless exists to support independent artists," said Threadless Founder and CEO, Jake Nickell. "We make it simple for an artist to get their work in the hands of their fans by opening up access to our nearly 20 years of experience in ecommerce merchandising, branding, marketing, product manufacturing, order fulfillment, and technology."

Threadless launched their customizable online merch platform, Artist Shops, in 2016 to allow artists like Pyle to monetize their art as their own brand. With Artist Shops, individuals upload their art and transform it into merch-ready, tangible products their customers can buy. Threadless handles logistics for Artist Shops owners like manufacturing, order fulfillment, and customer service. Currently, the platform hosts over 250,000 unique Artist Shops.

For more information on Threadless and Nathan W. Pyle's Strange Planet webcomicwatch the brand's interview with Nathan on http://www.youtube.com/ThreadlessXNathanPyle, visitartistshops.com/strangeplanetand nathanwpyle.threadless.com, and follow @nathanwpylestrangeplanetand @threadless on Instagram, Facebook, and Twitter.

About Nathan W. Pyle Nathan W. Pyle is the #1 New York Times best seller of Strange Planet and best-selling author of NYC Basic Tips and Etiquette and 99 Stories I Could Tell. He is a former staff writer and illustrator for BuzzFeed. Though based in New York City, Nathan also travels the country speaking about creativity and storytelling.

About ThreadlessFounded in 2000, Threadless is an ecommerce apparel company and online artist community. Consumers vote on artist-submitted designs that become purchasable catalogue products. In 2016, Threadless launched the print-on-demand Artist Shops platform to make selling art online easier. The turnkey merchandise solution allows individuals, companies, and nonprofits to create their own custom-branded online store for free.

See the original post here:
Threadless and Strange Planet Viral Webcomic Creator, Nathan W. Pyle, Lead a New Wave of Wearable Art - Cherokee Tribune Ledger News

Oxford study explores links between personality and the gut microbiome – New Atlas

A new study out of Oxford University is suggesting there is a strong link between individual personality traits and gut microbiome composition. The research does not claim gut bacteria directly determines a persons personality, but instead reveals a distinct and perhaps bi-directional, association between behavior and the microbiome.

There has been growing research linking the gut microbiome to the brain and behavior, known as the microbiomegutbrain axis, says the studys author, Katerina Johnson. Most research has been conducted in animals, whilst studies in humans have focused on the role of the gut microbiome in neuropsychiatric conditions. In contrast, my key interest was to look in the general population to see how variation in the types of bacteria living in the gut may be related to personality.

The new research grew out of a number of recent studies linking gut bacteria with autism. Not only have specific gut bacteria been associated with autism, but fecal transplants have been found to influence autistic behaviors in both animal and human studies. Johnsons study hypothesized that if certain types of gut bacteria had the capacity to influence autistic behaviors, then those same bacteria may be linked with certain basic personality traits such as sociability or neuroticism.

The studys conclusions did indeed back up the initial hypothesis. A number of species of gut bacteria previously linked with autism also correlated with sociability traits in healthy adults. Individuals with high sociability presented abundant levels of Akkermansia, Lactococcus and Oscillospira bacteria. All three genera have been identified in lower than average levels in autistic subjects.

On the other hand, Desulfovibrio and Sutterella were two genera found in high levels in those less sociable individuals with tendencies toward introversion. Again, both genera of bacteria have been identified in abundance in subject with autism.

More neurotic personalities could be detected by correlating lower levels of Streptococcus and Corynebacterium bacteria. Corynebacterium in particular has been linked to depression in animal models.

In general, the study detected a consistent correlation between gut microbiome diversity and individual sociability. So essentially, the larger a persons social network, the more diverse their gut microbiome. On this point Johnson hypothesizes a certain degree of social transmission of some micro-organisms may be at play.

The relationship between gut microbiome diversity and human social networks has not previously been explored but the positive relationship found here suggests that social interactions may also influence the microbiota of human societies, Johnson writes in the study. Interestingly, a study of gut microbiome composition and temperament in infants reported an association between gut microbiome diversity and sociability.

Other more general, and somewhat unsurprising, findings in the study suggest greater microbiome diversity is associated with frequent international travel. And, greater diversity was also linked with diets high in fermented and prebiotic foods.

Interestingly, probiotics taken in the form of supplements correlated with decreased microbiome diversity. Johnson points out this unexpected correlation is most likely due to the tendency of persons with gut health problems to be taking probiotic supplements.

Ultimately, the study does not intend to imply direct causation between gut bacteria and personality traits, but instead Johnson stresses the relationships seen here are most likely bi-directional. As she notes in the studys conclusion, gut bacteria can affect behavior and behavior can in turn influence the composition of the gut microbiome.

Still, this fundamental, almost symbiotic relationship, between a persons microbiome and their overall behavior or well-being is what Johnson suggests is the takeaway from the comprehensive study. If we accept a growing body of research associating extreme traits seen in psychiatric disorders with gut bacteria, then it is not unreasonable to link moderate behavioral variations in general healthy adults with the microbiome. However, it certainly isnt as simple as a single bacterial species causing a person to exhibit an extroverted personality.

Our modern-day living may provide a perfect storm for dysbiosis of the gut, says Johnson. We lead stressful lives with fewer social interactions and less time spent with nature, our diets are typically deficient in fibre, we inhabit oversanitized environments and are dependent on antibiotic treatments. All these factors can influence the gut microbiome and so may be affecting our behavior and psychological well-being in currently unknown ways.

The new study was published in the Human Microbiome Journal.

Source: Oxford University

See the rest here:
Oxford study explores links between personality and the gut microbiome - New Atlas

Unlocking the Secrets of Organ and Limb Regeneration From a Tiny Salamanders Genetics – SciTechDaily

Since humans possess similar genes to the axolotl, the researchers say, scientists may one day discover how to activate them to help speed wound repair or regenerate tissue.

The type of salamander called axolotl, with its frilly gills and widely spaced eyes, looks like an alien and has other-worldly powers of regeneration. Lose a limb, part of the heart or even a large portion of its brain? No problem: They grow back.

It regenerates almost anything after almost any injury that doesnt kill it, said Parker Flowers, postdoctoral associate in the lab of Craig Crews, the John C. Malone Professor of Molecular, Cellular, and Developmental Biology and professor of chemistry and pharmacology.

If scientists can find the genetic basis for the axolotls ability to regenerate, they might be able to find ways to restore damaged tissue in humans. But they have been thwarted in the attempt by another peculiarity of the axolotl it has the largest genome of any animal yet sequenced, 10 times larger than that of humans.

It regenerates almost anything after almost any injury that doesnt kill it. Parker Flowers

Now Flowers and colleagues have found an ingenious way to circumvent the animals complex genome to identify at least two genes involved in regeneration, they report today (January 28, 2020) in the journal eLife.

The advent of new sequencing technologies and gene-editing technology has allowed researchers to craft a list of hundreds of gene candidates that could responsible for regeneration of limbs. However, the huge size of the axolotl genome populated by vast areas of repeated stretches of DNA has made it difficult to investigate the function of those genes.

Lucas Sanor, a former graduate student in the lab, and fellow co-first author Flowers used gene editing techniques in a multi-step process to essentially create markers that could track 25 genes suspected of being involved in limb regeneration. The method allowed them to identify two genes in the blastema a mass of dividing cells that form at the site of a severed limb that were also responsible for partial regeneration of the axolotl tail.

Flowers stressed that many more such genes probably exist. Since humans possess similar genes, the researchers say, scientists may one day discover how to activate them to help speed wound repair or regenerate tissue.

Reference: Multiplex CRISPR/Cas screen in regenerating haploid limbs of chimeric Axolotls by Lucas D Sanor, Grant Parker Flowers and Craig M Crews, 28 January 2020, eLife.DOI: 10.7554/eLife.48511

Read this article:
Unlocking the Secrets of Organ and Limb Regeneration From a Tiny Salamanders Genetics - SciTechDaily

South Africa: wild animals at risk of ‘genetic pollution’ – The Guardian

Lions, rhinos and cheetahs are among the wild species at risk of irreversible genetic pollution from breeding experiments, scientists have warned.

South African game farmers have increasingly been breeding novel trophy animals, including some freakishly-coloured varieties such as the black impala, golden wildebeest or pure-white springboks.

Some hunters pay more to bag unusual trophies, but now the South African government is under fire for permitting further gene manipulation ventures that scientists say could have a damaging effect on the continents wildlife.

Writing in the latest issue of the South African Journal of Science, a group of 10 senior wildlife scientists and researchers have criticised the government for quietly amending the countrys Animal Improvement Act last year to allow for the domestication and genetic improvement of at least 24 indigenous wildlife species including rare and endangered animals such as rhino, cheetah, lion, buffalo and several antelope species.

The researchers warn that: A logical endpoint of this legislation is that we will have two populations of each species: one wild and one domesticated domesticated varieties of wildlife will represent a novel, genetic pollution threat to South Africas indigenous wildlife that will be virtually impossible to prevent or reverse.

Lead author Prof Michael Somers, a senior researcher at the Mammal Research Institute at the University of Pretoria, says the government should scrap the controversial law amendment which lumps together rare and endangered species such as rhinos with rabbits and domesticated dog breeds.

Somers and his colleagues say the act typically provides for domesticated species to be bred and genetically improved to obtain superior domesticated animals with enhanced production and performance.

These animals can also be used for genetic manipulation, embryo harvesting, in-vitro fertilisation and embryo transfers, say the scientists.

They argue that the law will not improve the genetics of the affected wildlife species but rather will pose ecological and economic risks as it will be expensive and almost impossible to maintain a clear distinction between wild and domesticated species.

Somers and his colleagues say the government did not appear to have consulted either scientists, government wildlife agencies or the general public about the controversial move.

Last year, in response to concerns that the legal amendment would remove the listed species from the ambit of conservation legislation, the governments environment department issued a statement to emphasise that that game breeders would still have to comply with the National Environmental Management Biodiversity Act and regulations concerning threatened or protected species.

But Somers and his co-authors remain concerned, saying that in the province of KwaZulu-Natal, where there is close cooperation between game breeders and the provincial conservation organisation, the authorities still had difficulty keeping track of what happens on game farms and in enforcing legislation.

This new law will add to this difficulty, and will likely be less controlled in some other provinces, they said, adding that the genetic consequences of intensive or semi-intensive breeding of wildlife species were negative and considerable.

Intensive breeding through artificial (non random) selection of individuals for commercially valuable traits (eg horn size/shape, coat colour) represents humans taking over this natural process. Such artificial selection by humans is even more powerful than natural selection in creating distinct phenotypes within very short time frames.

Michael Bruford, a professor of biodiversity at the University of Cardiff and co-chair of the Conservation Genetics Specialist Group of the IUCN Species Survival Commission, added his support to the concerns raised. The Convention on Biological Diversitys 2020 targets clearly state that signatory countries should minimise genetic erosion (loss of genetic diversity) in domestic, socio-economically and culturally valuable species, he said.

However you regard these species and they cannot reasonably be classified as domestic animals South Africas proposal will very likely lead to genetic erosion, in contravention of the CBD target, he added. This proposal also comes at a time of rapid environmental deterioration, when we need to be increasing the resilience of our species by ensuring they retain as much genetic diversity as possible.

See the original post:
South Africa: wild animals at risk of 'genetic pollution' - The Guardian

Mota Ventures gets access to Canada"s largest live genetic cannabis library via deal with Phenome One – Proactive Investors USA & Canada

Phenome One is a private genetic and seed preservation company with over 350 cultivars and access to around 1,700 unique genetics

Corp () (OTCMKTS:PEMTF) announced a new agreement Tuesday that gives the firm access to Canadas largest live genetic cannabis library.

The Vancouver-based company signed a licensing and royalty agreement with Phenome One Corporation, a private genetic and seed preservation company with over 350 cultivars and access to around 1,700 unique genetics in its seed bank.

Under the terms of the deal, Mota has the right to propagate, cultivate, harvest and process at least 10 selected cultivars from Phenomes genetic library and to sell anything it produces from the selections.

The agreement also grants unlimited access to the intellectual property and catalogue of Norstar Nutrients, a wellness company that offers blends of macro and micro-nutrients formulated for essential oils.

Mota may also tap into Phenomes farming intellectual property, the company said in a statement. Phenomes unique CBD strains have profiles ranging from 1:1 up to 150:1 CBD.

"We are excited to have finalized a licensing agreement with Phenome, as it gives us access to a significant genetic cannabis library, with some unique CBD strains having profiles of up to 150:1, Motas CEO Joel Shacker said in a statement.

The transaction sees Mota issuing 1 million shares to Phenome once the firm completes seed registration in Colombia. It will also make a monthly royalty payment to Phenome of 5% of gross sales of any product produced from Phenomes genetics.

Mota will also issue 1 million shares to Phenome if it is acquired by a third party or there is a material breach in the licensing agreement, it said in a statement.

The cannabis company also said it has terminated the previously announced acquisition of Tropical Verde Coast Ltd with no liabilities.

Contact Angela at [emailprotected]

Follow her on Twitter @AHarmantas

View original post here:
Mota Ventures gets access to Canada"s largest live genetic cannabis library via deal with Phenome One - Proactive Investors USA & Canada

Eisai and PGDx jointly start R&D of cancer genetics panel test – BSA bureau

Eisai and Personal Genome Diagnostics (PGDx) will use liquid biopsy to accelerate Next-Generation drug discovery and development

Japanese firm Eisai Co., Ltd., has entered into a joint research and development agreement with Personal Genome Diagnostics Inc., Maryland, for cancer genetics panel test, and it has initiated the research.

In this joint research and development, Eisai and PGDx will create a kitted cancer gene panel test that enables comprehensive analysis of mutation in more than 500 cancer gene using liquid biopsy with blood samples. Additionally, the kit will be used in our drug discovery and development.

In Eisai's medium term business plan EWAY2025, Eisai is pursuing creating innovation focused in neurology area and oncology area aimed at realizing prediction / prevention and cure. Aiming to acquire next-generation sequencing technology for realizing personalized cancer medicine, Eisai has concluded a joint research and development agreement with PGDx, a US bio-venture with liquid biopsy genomic expertise.

By analyzing the circulating tumor DNA (ctDNA) in the blood using its own created gene panel testing technology, Eisai will investigate the Cancer Evolution, which is a series of process such as developments of cancer cells, recurrence / metastasis and the appearance of acquired drug resistance. Eisai will also identify genetic abnormalities of drug resistance to existing anti-cancer agents that will be the targets of a new drug discovery and use a kitted cancer gene panel test for clinical trials to develop new anticancer drugs. Eisai will continue to work on cancer genome medicine for realizing early detection of cancer, and providing personalized cancer medicine and cures for cancer patients in the future.

In addition to accelerating cancer genome medicine based on the latest liquid biopsy technology, Eisai aims to build an oncology ecosystem, in which a longitudinal trajectory of cancer patients will be monitored, to lead to the creation of cures for cancer patients as well as diagnosis for prediction and prevention of cancer. Eisai will make continuous efforts to meet diversified needs of, and increasing the benefits provided to, patients with cancer, their families, and healthcare professionals.

Read the original post:
Eisai and PGDx jointly start R&D of cancer genetics panel test - BSA bureau

Using the logic of neuroscience to heal from a breakup – Big Think

While the feeling of being in love is seemingly magical, there are scientific reasons why being in love feels so good. And as such, there are scientific reasons why falling out of love or going through the heartache of a breakup feels so awful.

Biological anthropologist and well-respected human behavior researcher Dr. Helen Fisher published a groundbreaking study in 2005 that included the very first functional MRI images of the brains of people who were in the midst of "romantic love".

The team of researchers, led by Dr. Fisher, analyzed 2500 brain scans of students who viewed photos of someone special to them (in a romantic capacity) and compared those with scans taken of students who viewed photos of acquaintances.

In the instances where people were shown photos of individuals that they were romantically involved with, the brain would show activity in regions such as the caudate nucleus, which is a region of the brain associated with reward detection and the ventral tegmental area of the brain, which is associated with pleasure and motivation.

These are also areas of the brain that are rich with dopamine, which is a type of neurotransmitter that plays a big role in feeling pleasure. The role of dopamine in our system is to activate the reward circuit, which makes whatever we're doing at the time a more pleasurable experience that can be equated to the type of euphoria associated with the use of addictive substances such as cocaine or alcohol.

Not only does the human brain work to amplify positive emotions when it experiences love, but the neural pathways that are responsible for negative emotions such as fear are deactivated. When we are engaged in what is considered "romantic love," the neural mechanism that is responsible for making assessments of other people and formulating fear-based thoughts shuts down.

A 2011 study conducted at Stony Brook University in New York (which also included Dr. Fisher) concluded that it's possible to feel these effects with someone even after decades of marriage.

The study looked at MRI scans of couples who had been married an average of 21 years, and while the euphoria that comes with falling in love may have changed, the same heightened levels of activity in dopamine-rich areas of the brain that were found in new couples were also seen on these MRI scans.

When we are in love, our bodies are actively producing feel-good hormones and denying the release of negative hormones - and when this process suddenly stops, the "withdrawal" we feel can be extremely difficult to process both on an emotional and physiological level.

A study performed by researchers Lucy Brown, Xiomeng Xu, and Dr. Fisher scanned the activity in the brains of 15 young adults who had all experienced unwanted breakups yet still reported feeling "in love" with the person.

All of these individuals were in various stages of break up. Some still sent messages to their loved ones that went unanswered, and some simply feeling depressed that the relationship was over.

The individuals were shown photos of their former partners, and the scans taken during this time showed activity in several different areas of the brain, including the ventral tegmental, the ventral striatum, and the nucleus accumbens. All three areas are a part of our reward/motivation system, which communicates through the release of dopamine.

There is a direct link between those who have experienced rejection from someone they love (an ex-partner, for example) and those who have experienced withdrawal from addictive substances.

"Romantic love can be a perfectly wonderful addiction when it's going well...and a perfectly horrible addiction when it's going poorly."

- Helen Fisher

According to Dr. Guy Winch, psychologist and author of "How to Fix a Broken Heart," heartbreak is a form of grief and loss that can cause serious issues with insomnia, anxiety and even depression or suicidal thoughts. According to Winch, who is known to specialize in "emotional first aid," heartbreak should be taken very seriously, as should our efforts to recover from it.

Columbia University cognitive neuroscientist Edward Smith completed a series of studies and tests in 2011 that proved the pain we feel during heartbreak is similar to physical pain we might feel due to a severe burn or broken arm.

In these studies, the goal was to see what happens in the brains of people who have recently been through a breakup with a long-term partner.

In the MRI images of these people struggling with recent heartbreak, the parts of the brain that lit up were the same parts of the brain that are active when you experience physical pain.

Dr. Winch, in an interview with Blinkist Magazine, explained a similar study that he was a part of where physical pain that was rated as level 8 (on a scale of 1-10, with 10 being almost intolerable pain) showed similar results to an MRI taken by someone who had just talked about and relived their breakup.

The physical pain, which only lasted 7 seconds, registered the same in the patient's brain as the emotional pain of the breakup, which for some can last for days, weeks, or even months.

Understanding this link between heartbreak and physical pain should allow us to take a more all-encompassing approach to heal from the pain of a breakup.

"It's not just about time and waiting it out - it's about taking steps." - Dr. Guy Winch

Photo by Tero Vesalainen on Shutterstock

There are a few things we can do that are essential to surviving and healing from heartbreak, based on what we know from these studies.

Avoiding visual reminders of your ex-partner may seem like an obvious answer to help you recover, but sentimental reminders such as pictures or revisiting places you used to spend time with them are very likely to create dopamine surges in your brain that relate to feelings of craving and withdrawal.

Replacing those surges of dopamine is the next positive step: taking up a fitness class or joining a gym is something many people do to "power through" a breakup, but exercise can also lead to the release of endorphins that trigger a positive feeling throughout the body and brain.

Finding a "new normal" after a heartbreak can seem impossible - but one of the first things you need to do is to recalibrate your mind. Making a list of reasons your ex-partner wasn't perfect or being honest with yourself about parts of that relationship that were negative or unhealthy can be the beginning of resetting your system to see things in a more true light.

According to Dr. Winch, one of the biggest hurdles to recalibrating your mind and adapting to life without your ex-partner is that we don't find closure.

Winch suggests that we try to accept the reason for the breakup or even find another reason. Maybe the relationship would not have worked out because you wanted different things in life or because they were not emotionally available for you. Finding logic in heartbreak can be a good start to the healing process.

From Your Site Articles

Related Articles Around the Web

Excerpt from:
Using the logic of neuroscience to heal from a breakup - Big Think

Decoding the Brain Goes Global With the International Brain Initiative – Singularity Hub

Few times in history has mankind ever united to solve a single goal. Even the ultimate moonshot in historyputting a man on the moonwas driven by international competition rather than unification.

So its perhaps fitting that mankind is now uniting to understand the organ that fundamentally makes us human: our brain. First envisioned in 2016 through a series of discussions on the grand challenges in neuroscience at Johns Hopkins University, the International Brain Initiative (IBI) came out this week in a forward-looking paper in Neuron.

Rather than each country formulating their own brain projects independently, the project argues, its high time for the world to come together and share their findings, resources, and expertise across borders. By uniting efforts, the IBI can help shape the future of neuroscience research at a global scalefor promoting brain and mental health, for stimulating international collaboration, for ethical neuroscience practices, and for crafting future generations of scientists.

It takes a world to understand the brain, said Caroline Montojo of the Kavli Foundation, which offered support to the project. When we have the best brains and the best minds working together, sharing information and research that could benefit us all.

The initiative, at the time of writing, includes Japans Brain/Minds, Australian Brain Alliance, the EUs Human Brain Project (HBP), Canadian Brain Research Strategy, the US BRAIN Initiative (BRAINI), the Korea Brain Initiative, and the China Brain Project.

The IBI comes at a time when global research divisions are prominent. Established national projects, such as the BRAINI and the HBP, have notably different goals at the operational level. The BRAINI, for example, prominently champions developing new tools to study brain functions, whereas the HBPs ultimate goal is to recreate the function of a human brain inside machines.

Even within single countries, divisions in practical paths forward have been, mildly put, chaotic. Chinas Brain Project, announced officially in 2016 and kicked off two years later, was plagued by different opinions on focus: should it be on solving brain disorders, or understanding the neurobiology behind cognition, or focused on engineering problems that more intimately link human brains with AI?

Then theres the underlying political milieu, where certain countries are cracking down on international researchers for fear that they may be stealing or selling trade secrets. To all these divisions, the IBI took a stance and said noits time to work together.

The biggest challenge that were facing is to really understand how the brain works, the mystery of the brain, to crack the code, said Dr. Yves De Koninck of the Canadian Brain Research Strategy. If were going to make the really big leap changes in the level of understanding of how the brain works in health and disease, we need to have global collaboration, I mean thats just absolutely vital, added Dr. Linda Lanyon at the IBI Data Standards and Sharing Working Group.

The IBI is best viewed as a grassroots organization driven by the views of neuroscientists across the globe, rather than a bureaucratic entity following the views of a select few. In a way, the IBI organizes itself similar to the United Nations, with a five-year strategic plan, multiple working groups, and a governance structure.

Its clear that the IBI benefited from a global recognition, and subsequent establishment, of large-scale neuroscience projects to understand the brain. Yet any single initiative is like the blind men and the elephant parabledespite millions (or even billions) of dollars in investment, due to the brains complexity each can only probe a small part of human brain function.

However, even with different end goals, findings from each project will likely benefit each otherif properly shared in an easily-interpretable manner (the Kavli Foundation also backs a standardized format for neuroscience data called Neurodata Without Borders 2.0). Tools developed from BRAINI, for example, will likely benefit brain mapping initiatives around the world, and neural simulations can inspire insights into brain disorders or better paths towards brain-machine interfaces. A synergistic international effort could provide greater overall impact and better utilization of precious research funding, the authors argued.

Working across political aisles is already tough; now imagine sharing terabytes of data across international borders to someone you hardly know. The IBI aims to provide a platform that explores new models of collaboration among scientists so that, to put it bluntly, no one gets screwed out of their recognition. In addition, the IBI also works outside the ivory tower with private and public funding bodies, industry partners, and government-related agencies on the social, economic, and ethical impacts of neuroscientific discoveries and their translation.

Thats huge. The initiative comes at a time when technological advances are increasingly making it easier to skirt ethical considerations and move forward with iffy research projects. Making human-animal hybrid embryos to understand the roots of intelligence? Conducting brain stimulation trials that may slowly change a persons personality? Linking multiple human minds into computers by probing their brain waves? These futuristic projects abound and will only grow in number as our ability to crack the neural code improves.

The IBI argues that neuroscientists across the globe need to take a moral stancesimilar to emerging projects for ethical AIto guide research in an ethical manner. With several countries infamous for pushing moral boundaries also joining the alliance, the IBI may put an international leash on less-savory projects going forward, while respecting diverse cultural frameworks.

IBI group members stressed that the initiative isnt meant to be bureaucratic. Rather, its adaptive and allows the organization to be shaped by the scientific community over time, the authors said. Integrating multiple goals of various brain projects together, the IBI serves as meta-middleman to promote coordination, share resources, and help unite different ideas on the future of neuroscience.

This IBI is quite unique in trying to go from the very microscopic scale of the synapses that encode information within the brain, all the way up to how the information manifests itself in human cognition and animal behavior, said Dr. Linda Richards of the Australian Brain Alliance.

Despite being years in the making, the initiative is just crossing the starting line. With a solid infrastructure now in place and enthusiasm amassed, an immediate focus for the IBI is to establish and develop the core working groups that are making progress toward short-term deliverables, the authors said. The execution of a five-year plan to propel neuroscience research forward will need considerable debates on specific aims, approaches, and technologies, but will also add to a foundation for collaboration and priority-setting across the world, they added.

This is a new era of neuroscience, where neuroscientists will have access to large datasets and new ways of sharing in a collaborative manner internationally, said Richards.

Is IBIs vision nave? Maybe. The most impactful technological advancements of our ageflight, nuclear weapons, conquering space, the Internethave all stemmed from the minds of a relatively small group of people working under duress from other people. But when it comes to truly understanding the brain, the basis of who we are and what we believe, the root cause of divided opinions and worldviews, the organ that could one day be directly manipulated and fundamentally alter humanity as a speciesfighting for a global consortium is the least we can do.

Image Credit: adike/Shutterstock.com

Go here to read the rest:
Decoding the Brain Goes Global With the International Brain Initiative - Singularity Hub

How the Striatum’s Cell Types Work Together To Keep Us Moving – Technology Networks

Researchers at Karolinska Institutet have mapped how different nerve cells in the brain's striatum process information to plan and execute our movements at just the right time and with the right vigour. The results, presented in the journal Cell Reports, show that different cell types in the striatum receive signals from completely different parts of the cerebral cortex and thus respond to different types of information.

Many behaviours occur in response to sensory input from our environment. For example, when playing a new piece on the piano, we adjust our finger movements according to the sound we hear and the sensory feedback from the keys. Researchers at Karolinska Institutet in Sweden aimed to increase our understanding of how this works by studying the neuronal network that allows us to align our planned movements to sensory information such as touch. The nerve cells (neurons) that underlie this function are in the striatum, which is part of a larger structure in the brain called the basal ganglia.

While playing piano, sensory feedback from our fingertips is processed in the somatosensory cortex, the brain area specialised for touch. Movements are planned in a separate part of the brain called motor cortex. Information from the somatosensory cortex, the motor cortex and other brain areas such as thalamus are sent to the striatum, which is the first instance where movement plans and sensory information are combined. Based on the broad information delivered by these inputs, the striatum is able to generate a precisely timed output signal that is sent back to the muscles and allows us to press the next keys correctly on the piano.

"Although it has long been known that the striatum is composed of different types of nerve cells, it is unclear how striatal cells achieve this complex function," says Yvonne Johansson, PhD student at the Department of Neuroscience, Karolinska Institutet. "To address this question, we asked which striatal cell populations process which incoming information."

The researchers have used optogenetics, among other technologies, to analyse which of five important cell types in the striatum are responsible for the communication from the motor cortex, the somatosensory cortex and the thalamus.

Studies on mice revealed that striatal medium spiny neurons strongly respond to sensory inputs representing a sensation of touch. Another class of striatal neurons, the low-threshold spiking interneurons, hardly respond to inputs carrying sensory information but are strongly activated by inputs from motor cortex. In sharp contrast, cholinergic interneurons respond most strongly to thalamic inputs which are thought to notify us that something important is happening in our environment.

The researchers also found that the responses of the different neuron classes are mediated by different receptor compositions. As some receptors open faster than others, the receptors strongly shape the timing of the response.

The findings shed new light on how the striatum is systematically processing the vast amount of information that it receives.

"Our work shows that the flow of information into the striatal network is highly organised and that the properties of the numerous inputs targeting different striatal neuron populations are pathway-specific," says Gilad Silberberg, professor at the Department of Neuroscience, Karolinska Institutet.

Reference: Johansson, Y., & Silberberg, G. (2020). The Functional Organization of Cortical and Thalamic Inputs onto Five Types of Striatal Neurons Is Determined by Source and Target Cell Identities. Cell Reports, 30(4), 1178-1194.e3. https://doi.org/10.1016/j.celrep.2019.12.095

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read more:
How the Striatum's Cell Types Work Together To Keep Us Moving - Technology Networks

Decibel Therapeutics Announces Strategic Research Focus on Regenerative Medicine for the Inner Ear – Yahoo Finance

Company signs option agreement with The Rockefeller University to access intellectual property covering compounds targeting key regeneration pathway

Decibel Therapeutics, a development-stage biotechnology company developing novel therapeutics for hearing loss and balance disorders, today announced a new strategic research focus on regenerative medicine approaches for the inner ear. The company is also announcing a collaboration and option agreement that gives Decibel exclusive access to novel compounds targeting proteins in a critical regenerative pathway.

Decibels research focus on regeneration will be powered by the companys research and translation platform. The company has built one of the most sophisticated single cell genomics and bioinformatics platforms in the industry to identify and validate targets. Decibel has also developed unique insights into regulatory pathways and inner ear delivery mechanisms that together enable precise control over gene expression in the inner ear and differentiate its AAV-based gene therapy programs.

"Our deep understanding of the biology of the inner ear and our advanced technological capabilities come together to create a powerful platform for regenerative medicine therapies for hearing and balance disorders," said Laurence Reid, Ph.D., acting CEO of Decibel. "We see an exciting opportunity to leverage this platform to address a broad range of hearing and balance disorders that severely compromise quality of life for hundreds of millions of people around the world."

The first program in Decibels regeneration portfolio aims to restore balance function using an AAV-based gene therapy (DB-201), which utilizes a cell-specific promoter to selectively deliver a regeneration-promoting gene to target cells. In collaboration with Regeneron Pharmaceuticals, Decibel will initially evaluate DB-201 as a treatment for bilateral vestibulopathy, a debilitating condition that significantly impairs balance, mobility, and stability of vision. Ultimately, this program may have applicability in a broad range of age-related balance disorders. There are currently no approved medicines to restore balance. Decibel expects to initiate IND-enabling experiments for this program in the first half of 2020.

Decibel is also pursuing novel targets for the regeneration of critical cells in both the vestibule and cochlea of the inner ear; these targets may be addressable by gene therapy or other therapeutic modalities. As a key component of that program, Decibel today announced an exclusive worldwide option agreement with The Rockefeller University, which has discovered a novel series of small-molecule LATS inhibitors. LATS kinases are a core component of the Hippo signaling pathway, which plays a key role in regulating both tissue regeneration and the proliferation of cells in the inner ear that are crucial to hearing and balance. The agreement gives Decibel an exclusive option to license this series of compounds across all therapeutic areas.

The agreement also establishes a research collaboration between Decibel and A. James Hudspeth, M.D., Ph.D., the F.M. Kirby Professor at The Rockefeller University and the director of the F.M. Kirby Center for Sensory Neuroscience. Dr. Hudspeth is a world-renowned neuroscientist, a member of the National Academy of Sciences and the American Academy of Arts and Sciences, and a Howard Hughes Medical Institute investigator. Dr. Hudspeth has been the recipient of numerous prestigious awards, including the 2018 Kavli Prize in Neuroscience.

"Rockefeller scientists are at the leading edge of discovery, and we are excited to see the work of Dr. Hudspeth move forward in partnership with Decibel," said Jeanne Farrell, Ph.D., associate vice president for technology advancement at The Rockefeller University. "The ambitious pursuit of harnessing the power of regenerative medicine to create a new option for patients with hearing loss could transform how we address this unmet medical need in the future."

In parallel with its new research focus on regenerative strategies, Decibel will continue to advance key priority preclinical and clinical programs. DB-020, the companys clinical-stage candidate designed to prevent hearing damage in people receiving cisplatin chemotherapy, is in an ongoing Phase 1b trial. Decibel will also continue to progress DB-OTO, a gene therapy for the treatment of genetic congenital deafness, which is being developed in partnership with Regeneron Pharmaceuticals. The DB-OTO program aims to restore hearing to people born with profound hearing loss due to a mutation in the otoferlin gene and is expected to progress to clinical trials in 2021.

Story continues

To support the new research focus, Decibel is restructuring its employee base and discontinuing some early-stage discovery programs.

About Decibel Therapeutics, Inc.Decibel Therapeutics, a development-stage biotechnology company, has established the worlds first comprehensive drug discovery, development, and translational research platform for hearing loss and balance disorders. Decibel is advancing a portfolio of discovery-stage programs aimed at restoring hearing and balance function to further our vision of a world in which the benefits and joys of hearing are available to all. Decibels lead therapeutic candidate, DB-020, is being investigated for the prevention of ototoxicity associated with cisplatin chemotherapy. For more information about Decibel Therapeutics, please visit decibeltx.com or follow @DecibelTx.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200129005162/en/

Contacts

Matthew Corcoran, Ten Bridge Communicationsmcorcoran@tenbridgecommunications.com (617) 866-7350

Originally posted here:
Decibel Therapeutics Announces Strategic Research Focus on Regenerative Medicine for the Inner Ear - Yahoo Finance